Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
anti-thymocyte globulin
Ultragenyx UK Limited
Purpura, Schoenlein-Henoch
1 trial -
antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
araboxylan
Sun Yat-sen University
Subjects With Hyperuricemia
1 trial -
atosiban
Hospital Authority, Hong Kong
Repeated Implantation Failure
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory Aplastic Anemia
1 trial -
bicycle ergometry test with spiroergometry
The First People's Hospital of Lianyungang
Community-acquired Pneumonia
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial -
blood draw from three different vessels
Sionna Therapeutics
Accidental Hypothermia
1 trial -
blood sampling
Marker Therapeutics
Colorectal Cancer Screening
1 trial -
blood sampling
Marker Therapeutics
Screening for Colon Cancer
1 trial -
blood sampling (alpha-Galactosidase & LysoGb3)
Takeda
Fabry Disease
1 trial -
botulinum toxin type A
Ultragenyx UK Limited
Hyperhidrosis
1 trial -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
buprenorphine and low-dose naloxone
Indivior Pty Ltd
Pain
1 trial -
caFFR
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
calcitriol
Ultragenyx UK Limited
Psoriasis
1 trial -
carbohydrates
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Insulin Resistance
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial -
caspofungin
Beijing Chao Yang Hospital
Pneumocystis Pneumonia
1 trial -
cefditoren pivoxil tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Medication Safety
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources